New Treatment Option Approved for Advanced Womb Cancer in England
A new treatment combining KEYTRUDA (pembrolizumab) with chemotherapy has been recommended by NICE for adults with advanced or recurrent womb […]
Browsing category
A new treatment combining KEYTRUDA (pembrolizumab) with chemotherapy has been recommended by NICE for adults with advanced or recurrent womb […]
The Food and Drug Administration (FDA) has introduced a new program called ‘FDA PreCheck’ to help strengthen U.S. drug production. […]
Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in […]
Dr. George Tidmarsh, a physician, academic, and biotech entrepreneur, has been appointed as the new director of the FDA’s Center […]
AstraZeneca has received a positive recommendation from NICE (the National Institute for Health and Care Excellence) for a new combination […]
President Donald Trump has warned 17 major drug companies that they must lower their prices to match those in other […]
President Trump has sent letters to major drug companies, urging them to lower prices in the U.S. to match the […]
4TEEN4 Pharmaceuticals has started testing a new drug called procizumab in patients with cardiogenic shock, a life-threatening condition where the […]
A new £4.8 billion ($6.45 billion) free trade agreement (FTA) between the UK and India is expected to create new […]
After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only […]